StockData
Vistagen Therapeutics, Inc. logo

Vistagen Therapeutics, Inc. (VTGN) income statement

VTGNNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/3080% below fair value
$0.16−0.02 (-12.33%)

Close on Nov 20, 2026Market cap $7.26MP/E –Yield –

See a number that looks wrong?